journal article·2013-01Open access

Controlling fibrous capsule formation through long-term down-regulation of collagen type I (COL1A1) expression by nanofiber-mediated siRNA gene silencing

Pim-on Rujitanaroj, Brian Jao, Junghoon Yang, Feng Wang, James M. Anderson, Jun Wang, Sing Yian Chew

Acta Biomaterialia· Volume 9· Issue 1

Abstract

The foreign body reaction often interferes with the long-term functionality and performance of implanted biomedical devices through fibrous capsule formation. While many implant modification techniques have been adopted in attempts to control fibrous encapsulation, the outcomes remained sub-optimal. Nanofiber scaffold-mediated RNA interference may serve as an alternative approach through the localized and sustained delivery of siRNA at implant sites. In this study, we investigated the efficacy of siRNA-poly(caprolactone-co-ethylethylene phosphate) nanofibers in controlling fibrous capsule formation through the down-regulation of collagen type I (COL1A1) in vitro and in vivo. By encapsulating complexes of COL1A1 siRNA with a transfection reagent (Transit TKO) or the cell penetrating peptides CADY or MPG within the nanofibers (550-650 nm in diameter), a sustained release of siRNA was obtained for at least 28 days (loading efficiency ~60-67%). Scaffold-mediated transfection significantly enhanced cellular uptake of oligonucleotides and prolonged in vitro gene silencing duration by at least 2-3 times as compared to conventional bolus delivery of siRNA (14 days vs. 5-7 days by bolus delivery). In vivo subcutaneous implantation of siRNA scaffolds revealed a significant decrease in fibrous capsule thickness at weeks 2 and 4 as compared to plain nanofibers (p<0.05). Taken together, the results demonstrated the efficacy of scaffold-mediated siRNA gene-silencing in providing effective long-term control of fibrous capsule formation.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (60)

Show source-provided references
1. Reducing capsular thickness and enhancing angiogenesis around implant drug release systems10.1016/S0168-3659(01)00502-8 ↗
2. Biological responses to materials10.1146/annurev.matsci.31.1.81 ↗
3. The promotion of stemness and pluripotency following feeder-free culture of embryonic stem cells on collagen-grafted 3-dimensional nanofibrous scaffold10.1016/j.biomaterials.2011.06.048 ↗
4. The glial scar and central nervous system repair10.1016/S0361-9230(99)00072-6 ↗
5. Screening mammography in 350 women with breast implants: prevalence and findings of implant complications10.2214/ajr.159.5.1414810 ↗
6. Role of immune cells and inflammatory cytokines in regulation of fibrosis around silicone expander implants10.1007/s10856-010-4015-7 ↗
7. Characterization of implantable biosensor membrane biofouling10.1007/s002160051556 ↗
8. Foreign-body giant cells and polyurethane biostability: in vivo correlation of cell adhesion and surface cracking10.1002/jbm.820250205 ↗
9. The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E ↗
10. The effect of microgeometry, implant thickness and polyurethane chemistry on the foreign body response to subcutaneous implants10.1016/S0142-9612(02)00160-6 ↗
11. Fibro-porous meshes made from polyurethane micro-fibers: effects of surface charge on tissue response10.1016/j.biomaterials.2004.03.030 ↗
12. The lightweight and large porous mesh concept for hernia repair10.1586/17434440.2.1.103 ↗
13. Effects of steroidal and non-steroidal drugs on the neovascularization response induced by tumoral TA3 supernatant on CAM from chick embryo10.4067/S0716-97602003000200013 ↗
14. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings10.1016/j.biomaterials.2004.07.069 ↗
15. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis10.1016/j.jconrel.2006.10.013 ↗
16. Long- and short-term effects of biological hydrogels on capsule microvascular density around implants in rats10.1002/1097-4636(2001)58:3<313::AID-JBM1023>3.0.CO;2-O ↗
17. Dexamethasone delays ulcer healing by inhibition of angiogenesis in rat stomachs10.1016/j.ejphar.2003.11.038 ↗
18. Calcitonin stimulates multiple stages of angiogenesis by directly acting on endothelial cells10.1158/0008-5472.CAN-05-0848 ↗
19. Biological roles of the delta family notch ligand Dll4 in tumor and endothelial cells in ovarian cancer10.1158/0008-5472.CAN-10-2719 ↗
20. Identification of novel therapeutic targets in microdissected clear cell ovarian cancers10.1371/journal.pone.0021121 ↗
21. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference10.1038/nbt1176 ↗
22. First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder10.1038/mt.2009.273 ↗
23. RNA interference by nanofiber-based siRNA delivery system10.1016/j.jconrel.2010.02.003 ↗
24. Nanofiber-mediated controlled release of siRNA complexes for long term gene-silencing applications10.1016/j.biomaterials.2011.04.065 ↗
25. Effect of fiber diameter and alignment of electrospun polyurethane meshes on mesenchymal progenitor cells10.1089/ten.tea.2008.0295 ↗
26. The effect of the alignment of electrospun fibrous scaffolds on Schwann cell maturation10.1016/j.biomaterials.2007.10.025 ↗
27. The topographical effect of electrospun nanofibrous scaffolds on the in vivo and in vitro foreign body reaction10.1002/jbm.a.32609 ↗
28. Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation10.1016/j.jconrel.2010.08.019 ↗
29. Lung delivery studies using siRNA conjugated to TAT (48–60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity10.1021/bc070077d ↗
30. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells10.1093/nar/gkg385 ↗
31. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells10.1038/mt.2008.215 ↗
32. Highly efficient small interfering RNA delivery to primary mammalian neurons induces microRNA-like effects before mRNA degradation10.1523/JNEUROSCI.3643-04.2004 ↗
33. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides10.1096/fj.06-6502com ↗
34. Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth10.1093/nar/gkp451 ↗
35. Cell-penetrating-peptide-mediated siRNA lung delivery10.1042/BST0350807 ↗
36. A peptide-based vector for efficient gene transfer in vitro and in vivo10.1038/mt.2011.10 ↗
37. Liposomal transfection efficiency and toxicity on glioma cell lines: in vitro and in vivo studies10.1097/00001756-199803300-00005 ↗
38. Delivery of siRNA from lyophilized polymeric surfaces10.1016/j.biomaterials.2007.10.003 ↗
39. Toxicity pathway focused gene expression profiling of PEI-based polymers for pulmonary applications10.1021/mp900278x ↗
40. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy10.1016/j.ymthe.2005.02.010 ↗
41. Kinetics and mechanism of 2-ethoxy-2-oxo-1,3,2-dioxaphospholane polymerization initiated by stannous octoate10.1021/ma0615396 ↗
42. Tunable thermosensitivity of biodegradable polymer micelles of poly(epsilon-caprolactone) and polyphosphoester block copolymers10.1021/ma900288t ↗
43. Peptide-based strategy for siRNA delivery into mammalian cells
44. Biocompatibility and biofouling of MEMS drug delivery devices10.1016/S0142-9612(02)00565-3 ↗
45. Macroporous condensed poly(tetrafluoroethylene). I. In vivo inflammatory response and healing characteristics10.1002/jbm.a.30481 ↗
46. Aligned protein–polymer composite fibers enhance nerve regeneration: a potential tissue-engineering platform10.1002/adfm.200600441 ↗
47. The influence of electrospun aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes10.1016/j.biomaterials.2008.03.031 ↗
48. Sciatic nerve regeneration in rats by a promising electrospun collagen/poly(epsilon-caprolactone) nerve conduit with tailored degradation rate10.1186/1471-2202-12-68 ↗
49. Engineering bi-layer nanofibrous conduits for peripheral nerve regeneration10.1089/ten.tec.2010.0565 ↗
50. Biomimetic surface modification of titanium surfaces for early cell capture by advanced electrospinning10.1088/1748-6041/7/1/015001 ↗
51. Ordered surfactant-templated poly(3,4-ethylenedioxythiophene) (PEDOT) conducting polymer on microfabricated neural probes10.1016/j.actbio.2004.09.006 ↗
52. A novel potent strategy for gene delivery using a single peptide vector as a carrier10.1093/nar/27.17.3510 ↗
53. Surface adsorption of DNA to tissue engineering scaffolds for efficient gene delivery10.1002/jbm.a.30643 ↗
54. A matrix reservoir for improved control of non-viral gene delivery10.1016/j.jconrel.2009.02.006 ↗
55. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro10.1007/s11095-006-9036-z ↗
56. Fibroblast differentiation in wound healing and fibrosis10.1016/S0074-7696(07)57004-X ↗
57. Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway10.1074/jbc.M401238200 ↗
58. Polymeric nanofibers in tissue engineering10.1089/ten.teb.2011.0238 ↗
59. Increasing the pore size of electrospun scaffolds10.1089/ten.teb.2011.0235 ↗
60. Increasing electrospun scaffold pore size with tailored collectors for improved cell penetration10.1016/j.actbio.2011.02.036 ↗